NCT00498745View on ClinicalTrials.gov

Study Comparing 2 New Formulations of HKI-272 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2007

Study Completion Date

September 30, 2007

Conditions
Healthy
Interventions
DRUG

neratinib

HKI-272

Trial Locations (1)

78217

San Antonio

All Listed Sponsors
lead

Puma Biotechnology, Inc.

INDUSTRY

NCT00498745 - Study Comparing 2 New Formulations of HKI-272 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter